Trial · NCT02391961
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Pulse Size Ratio (PSR): Abducting/Adducting Eye Ratio for Saccadic Peak Velocity. | Dalfampridine | average pulse size ratio baseline | 1.914 | Standard Deviation 0.454 | ratio |
| Pulse Size Ratio (PSR): Abducting/Adducting Eye Ratio for Saccadic Peak Velocity. | Placebo | average pulse size ratio baseline | 1.937 | Standard Deviation 0.553 | ratio |
| Pulse Size Ratio (PSR): Abducting/Adducting Eye Ratio for Saccadic Peak Velocity. | Dalfampridine | average pulse size ratio after 3 hours | 1.805 | Standard Deviation 0.451 | ratio |
| Pulse Size Ratio (PSR): Abducting/Adducting Eye Ratio for Saccadic Peak Velocity. | Placebo | average pulse size ratio after 3 hours | 1.898 | Standard Deviation 0.508 | ratio |
| Pulse Time Delay (PTD): Time Difference Between Onset of the Saccade in the Adducting Eye and Onset of the Saccade in the Abducting Eye. | Dalfampridine | Average PTD at baseline | 0.007 | Standard Deviation 0.005 | seconds |
| Pulse Time Delay (PTD): Time Difference Between Onset of the Saccade in the Adducting Eye and Onset of the Saccade in the Abducting Eye. | Placebo | Average PTD at baseline | 0.007 | Standard Deviation 0.005 | seconds |
| Pulse Time Delay (PTD): Time Difference Between Onset of the Saccade in the Adducting Eye and Onset of the Saccade in the Abducting Eye. | Dalfampridine | Average PTD after 3 hours | 0.008 | Standard Deviation 0.004 | seconds |
| Pulse Time Delay (PTD): Time Difference Between Onset of the Saccade in the Adducting Eye and Onset of the Saccade in the Abducting Eye. | Placebo | Average PTD after 3 hours | 0.008 | Standard Deviation 0.004 | seconds |
| Reading Acuity (RA) | Dalfampridine | RA at baseline | 0.111 | Standard Deviation 0.117 | logMAR for RA |
| Reading Acuity (RA) | Placebo | RA at baseline | 0.108 | Standard Deviation 0.138 | logMAR for RA |
| Reading Acuity (RA) | Dalfampridine | RA after 3 hours | 0.088 | Standard Deviation 0.121 | logMAR for RA |
| Reading Acuity (RA) | Placebo | RA after 3 hours | 0.086 | Standard Deviation 0.141 | logMAR for RA |
| Maximum Reading Speed (MRS) | Dalfampridine | MRS at baseline | 156 | Standard Deviation 31 | words per minute |
| Maximum Reading Speed (MRS) | Placebo | MRS at baseline | 151.7 | Standard Deviation 20 | words per minute |
| Maximum Reading Speed (MRS) | Dalfampridine | MRS after 3 hours | 158 | Standard Deviation 19 | words per minute |
| Maximum Reading Speed (MRS) | Placebo | MRS after 3 hours | 158.7 | Standard Deviation 25 | words per minute |
| Gait Assessment | Dalfampridine | 25 FWT baseline | 8.986 | Standard Deviation 4.957 | seconds |
| Gait Assessment | Placebo | 25 FWT baseline | 9.113 | Standard Deviation 4.639 | seconds |
| Gait Assessment | Dalfampridine | 25 FWT after 3 hours | 8.567 | Standard Deviation 5.352 | seconds |
| Gait Assessment | Placebo | 25 FWT after 3 hours | 9.184 | Standard Deviation 5.400 | seconds |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02391961/results